Shu Y - Search Results

1

Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials.

Huang Z, Wu Y, Zhou X, Xu J, Zhu W, Shu Y, Liu P. Huang Z, et al. Among authors: shu y. Future Oncol. 2014 Aug;10(10):1795-807. doi: 10.2217/fon.14.30. Future Oncol. 2014. PMID: 25303058 Review.

2

Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells.

Wu H, Li W, Wang T, Shu Y, Liu P. Wu H, et al. Among authors: shu y. Biomed Pharmacother. 2008 Nov;62(9):659-66. doi: 10.1016/j.biopha.2008.08.002. Epub 2008 Aug 31. Biomed Pharmacother. 2008. PMID: 18809274

3

Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population.

Wu J, Lu Y, Ding YB, Ke Q, Hu ZB, Yan ZG, Xue Y, Zhou Y, Hua ZL, Shu YQ, Liu P, Shen J, Xu YC, Shen HB. Wu J, et al. Among authors: shu yq. Mol Carcinog. 2009 Jul;48(7):626-32. doi: 10.1002/mc.20502. Mol Carcinog. 2009. PMID: 19058298

4

A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.

Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H. Tian T, et al. Among authors: shu y. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1183-7. doi: 10.1158/1055-9965.EPI-08-0814. Epub 2009 Mar 17. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19293314

5

Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population.

Lu Y, Chen J, Ding Y, Jin G, Wu J, Huang H, Deng B, Hua Z, Zhou Y, Shu Y, Liu P, Hu Z, Shen J, Xu Y, Shen H. Lu Y, et al. Among authors: shu y. Int J Cancer. 2010 Nov 1;127(9):2183-9. doi: 10.1002/ijc.25228. Int J Cancer. 2010. PMID: 20131315

6

miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.

Zhu W, Shan X, Wang T, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Int J Cancer. 2010 Dec 1;127(11):2520-9. doi: 10.1002/ijc.25260. Int J Cancer. 2010. PMID: 20162574

7

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer.

Yin YM, Geng YT, Shao YF, Hu XL, Li W, Shu YQ, Wang ZX. Yin YM, et al. J Exp Clin Cancer Res. 2010 Sep 15;29(1):126. doi: 10.1186/1756-9966-29-126. J Exp Clin Cancer Res. 2010. PMID: 20843324 Free PMC article.

8

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study.

Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ. Shen H, et al. Int J Hyperthermia. 2011;27(1):27-32. doi: 10.3109/02656736.2010.500645. Epub 2010 Sep 21. Int J Hyperthermia. 2011. PMID: 20858088 Free article. Clinical Trial.

9

The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.

Liu L, Shao X, Gao W, Bai J, Wang R, Huang P, Yin Y, Liu P, Shu Y. Liu L, et al. Among authors: shu y. J Thorac Oncol. 2010 Dec;5(12):1922-32. doi: 10.1097/jto.0b013e3181f26266. J Thorac Oncol. 2010. PMID: 21155183 Free article.

10

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y, Liu P. Zhu W, et al. Among authors: shu y. Med Oncol. 2012 Mar;29(1):384-91. doi: 10.1007/s12032-010-9797-4. Epub 2011 Jan 22. Med Oncol. 2012. PMID: 21258880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,956 results

Search Page

Filters